• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析 STAT3 在犬骨肉瘤中的代谢作用。

Characterizing the metabolic role of STAT3 in canine osteosarcoma.

机构信息

Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA.

College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.

出版信息

Vet Comp Oncol. 2022 Dec;20(4):817-824. doi: 10.1111/vco.12841. Epub 2022 Jul 11.

DOI:10.1111/vco.12841
PMID:35608271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9669091/
Abstract

Signal transducer and activator of transcription 3 (STAT3) dysregulation has been characterized in canine OS, with previous data suggesting that constitutive STAT3 activation contributes to survival and proliferation in OS cell lines in vitro. Recently, the contribution of STAT3 to tumour metabolism has been described across several tumour histologies, and understanding the metabolic implications of STAT3 loss may elucidate novel therapeutic approaches with synergistic activity. The objective of this work was to characterize metabolic benchmarks associated with STAT3 loss in canine OS. STAT3 expression and activation was evaluated using western blotting in canine OS cell lines OSCA8 and Abrams. STAT3 was deleted from these OS cell lines using CRISPR-Cas9, and the effects on proliferation, invasion and metabolism (respirometry, intracellular lactate) were determined. Loss of STAT3 was associated with decreased basal and compensatory glycolysis in canine OS cell lines, without modulation of cellular proliferation. Loss of STAT3 also resulted in diminished invasive capacity in vitro. Interestingly, the absence of STAT3 did not impact sensitivity to doxorubicin in vitro. Our data demonstrate that loss of STAT3 modulates features of aerobic glycolysis in canine OS impacting capacities for cellular invasions, suggesting a role for this transcription factor in metastasis.

摘要

信号转导子和转录激活子 3(STAT3)失调已在犬骨肉瘤(OS)中得到表征,先前的数据表明,组成性 STAT3 激活有助于 OS 细胞系在体外的存活和增殖。最近,STAT3 对几种肿瘤组织学的肿瘤代谢的贡献已经被描述,了解 STAT3 缺失对代谢的影响可能阐明具有协同作用的新的治疗方法。这项工作的目的是表征与犬骨肉瘤中 STAT3 缺失相关的代谢基准。使用蛋白质印迹法在犬骨肉瘤细胞系 OSCA8 和 Abrams 中评估 STAT3 的表达和激活。使用 CRISPR-Cas9 从这些骨肉瘤细胞系中删除 STAT3,并确定其对增殖、侵袭和代谢(呼吸测定法、细胞内乳酸)的影响。STAT3 的缺失与犬骨肉瘤细胞系中基础和代偿性糖酵解的降低有关,而不会影响细胞增殖。STAT3 的缺失也导致体外侵袭能力的降低。有趣的是,STAT3 的缺失并不影响体外阿霉素的敏感性。我们的数据表明,STAT3 的缺失调节了犬骨肉瘤中有氧糖酵解的特征,影响了细胞侵袭的能力,提示该转录因子在转移中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/9e96a42b4980/VCO-20-817-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/cdae9e261dab/VCO-20-817-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/a3bfa8503deb/VCO-20-817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/2e470f7037f3/VCO-20-817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/61f07c6abbe1/VCO-20-817-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/9e96a42b4980/VCO-20-817-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/cdae9e261dab/VCO-20-817-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/a3bfa8503deb/VCO-20-817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/2e470f7037f3/VCO-20-817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/61f07c6abbe1/VCO-20-817-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9d/9796029/9e96a42b4980/VCO-20-817-g005.jpg

相似文献

1
Characterizing the metabolic role of STAT3 in canine osteosarcoma.解析 STAT3 在犬骨肉瘤中的代谢作用。
Vet Comp Oncol. 2022 Dec;20(4):817-824. doi: 10.1111/vco.12841. Epub 2022 Jul 11.
2
The safety and efficiency of photodynamic therapy for the treatment of osteosarcoma: A systematic review of in vitro experiment and animal model reports.光动力疗法治疗骨肉瘤的安全性和有效性:体外实验和动物模型报告的系统评价
Photodiagnosis Photodyn Ther. 2022 Dec;40:103093. doi: 10.1016/j.pdpdt.2022.103093. Epub 2022 Aug 27.
3
MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway and .miR362-3p 通过调控 IL6ST/JAK2/STAT3 通路缓解骨肉瘤 及其相关机制的研究
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241261616. doi: 10.1177/15330338241261616.
4
STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis.信号转导和转录激活因子3(STAT3)抑制与CD47阻断联合使用可抑制骨肉瘤肺转移。
Front Immunol. 2025 Jun 3;16:1608375. doi: 10.3389/fimmu.2025.1608375. eCollection 2025.
5
Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.整合素 αVβ1 激活的 PYK2 通过 STAT3-VGF 轴促进非小细胞肺癌的进展。
Cell Commun Signal. 2024 Jun 6;22(1):313. doi: 10.1186/s12964-024-01639-1.
6
The Anti-Metastatic Properties of Glutathione-Stabilized Gold Nanoparticles-A Preliminary Study on Canine Osteosarcoma Cell Lines.谷胱甘肽稳定的金纳米颗粒的抗转移特性——对犬骨肉瘤细胞系的初步研究
Int J Mol Sci. 2025 Jun 25;26(13):6102. doi: 10.3390/ijms26136102.
7
Danshen (Salvia miltiorrhiza) extract suppresses the growth of melanoma cells and induces autophagy by inhibiting the STAT3 pathway.丹参提取物通过抑制信号转导和转录激活因子3(STAT3)通路抑制黑色素瘤细胞的生长并诱导自噬。
J Ethnopharmacol. 2025 Jul 24;351:120086. doi: 10.1016/j.jep.2025.120086. Epub 2025 Jun 2.
8
Amputation and dexniguldipine as treatment for canine appendicular osteosarcoma.截肢术和地尼骨化醇作为犬附肢骨肉瘤的治疗方法。
J Cancer Res Clin Oncol. 1997;123(1):34-8. doi: 10.1007/BF01212612.
9
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.小窝蛋白-1通过表皮生长因子受体(EGFR)降解抑制肺腺癌的增殖和侵袭。
Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8.
10
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.

引用本文的文献

1
Pathobiology and Molecular Pathways Implicated in Osteosarcoma Lung Metastasis: A Scoping Review.骨肉瘤肺转移的病理生物学及分子机制:一项范围综述
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251359716. doi: 10.1177/15330338251359716. Epub 2025 Jul 17.
2
Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas.依非巴特抑制剂及其衍生物对人源和犬源骨肉瘤的抗肿瘤作用。
Sci Rep. 2024 Aug 20;14(1):19349. doi: 10.1038/s41598-024-69171-3.
3
Anti-tumor Effects of the eIF4A Inhibitor Didesmethylrocaglamide and Its Derivatives in Human and Canine Osteosarcomas.

本文引用的文献

1
Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.利用现有测序技术和生物信息学方法揭示原发性和转移性犬附肢骨肉瘤的混沌基因组图谱。
PLoS One. 2021 Feb 8;16(2):e0246443. doi: 10.1371/journal.pone.0246443. eCollection 2021.
2
Improving human cancer therapy through the evaluation of pet dogs.通过评估宠物狗来提高人类癌症疗法。
Nat Rev Cancer. 2020 Dec;20(12):727-742. doi: 10.1038/s41568-020-0297-3. Epub 2020 Sep 15.
3
Novel activators and small-molecule inhibitors of STAT3 in cancer.
真核生物翻译起始因子4A(eIF4A)抑制剂去二甲基罗卡酰胺及其衍生物对人及犬骨肉瘤的抗肿瘤作用
Res Sq. 2024 Jun 14:rs.3.rs-4494024. doi: 10.21203/rs.3.rs-4494024/v1.
癌症中 STAT3 的新型激活剂和小分子抑制剂。
Cytokine Growth Factor Rev. 2019 Oct;49:10-22. doi: 10.1016/j.cytogfr.2019.10.005. Epub 2019 Oct 22.
4
Efficacy of an anti-cancer strategy targeting SET in canine osteosarcoma.一种针对SET的抗癌策略在犬骨肉瘤中的疗效。
J Vet Med Sci. 2019 Oct 18;81(10):1424-1430. doi: 10.1292/jvms.19-0311. Epub 2019 Sep 13.
5
Cell Clustering Promotes a Metabolic Switch that Supports Metastatic Colonization.细胞聚类促进支持转移定植的代谢转换。
Cell Metab. 2019 Oct 1;30(4):720-734.e5. doi: 10.1016/j.cmet.2019.07.014. Epub 2019 Aug 22.
6
Canine osteosarcoma genome sequencing identifies recurrent mutations in and the histone methyltransferase gene .犬骨肉瘤基因组测序鉴定出 和组蛋白甲基转移酶基因 的反复突变。
Commun Biol. 2019 Jul 19;2:266. doi: 10.1038/s42003-019-0487-2. eCollection 2019.
7
Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.利用全外显子组测序鉴定犬癌细胞系中的潜在可成药靶点。
Mol Cancer Ther. 2019 Aug;18(8):1460-1471. doi: 10.1158/1535-7163.MCT-18-1346. Epub 2019 Jun 7.
8
Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors.针对癌基因成瘾性肿瘤中的 STAT3 和氧化磷酸化。
Redox Biol. 2019 Jul;25:101073. doi: 10.1016/j.redox.2018.101073. Epub 2018 Dec 13.
9
Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map.从组织修复中寻找治疗癌症的新靶点——利用 STAT3 活性
Nat Rev Cancer. 2019 Feb;19(2):82-96. doi: 10.1038/s41568-018-0090-8.
10
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.乳酸转运蛋白 MCT1 和 MCT4 的双重抑制与二甲双胍联合使用具有合成致死性,这是由于癌细胞中 NAD+ 的耗竭。
Cell Rep. 2018 Dec 11;25(11):3047-3058.e4. doi: 10.1016/j.celrep.2018.11.043.